PIIINasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIIIW

P3 Health Partners Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$3.81−0.33 (-7.97%)

Close on Oct 19, 2026

Market cap: $12.81M
P/E (TTM): –
Dividend yield: –

P3 Health Partners Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	1,459	1,500	1,266	1,049	491	145
Selling, General & Admin	107	114	126	162	55	37
Selling & Marketing	0.92	1.33	3.23	5.10	1.50	0.80
General & Administrative	106	113	122	157	53	36
Advertising Expenses	0.90	1.30	3.20	4.50	–	–
Operating Expenses	1,729	1,821	1,434	2,610	520	185
Operating Income	-270	-321	-168	-1,561	-29	-40
Other Non-Operating Income	-51	15	-16	1.22	-2.82	-2.44
Asset Impairment Charges	–	–	0	1,315	0	0
Gain (Loss) on Sale of Assets	-0.16	13	0	–	–	–
Pretax Income	-321	-306	-184	-1,560	-31	-42
Income Tax Expense	2.03	4.39	2.70	1.86	0	0
Net Income incl. Noncontrolling Interests	-323	-310	-186	-1,562	-31	-42
Minority Interest in Earnings	-175	-175	-129	-1,291	–	–
Net Income	-148	-136	-58	-270	-31	-42
Net Income to Common	–	–	–	-270	–	–
EPS (Basic)(per share)	-45.26	-46.78	-30.50	-325.00	–	–
EPS (Diluted)(per share)	-45.26	-54.06	-31.50	-325.00	–	–
Shares Outstanding (Basic, Weighted)(shares)	3.27	2.90	1.90	0.83	–	–
Shares Outstanding (Diluted, Weighted)(shares)	3.27	2.94	5.89	0.83	–	–
EBITDA	-186	-235	-81	-1,474	-28	-39
Net Interest Income	-55	-22	-16	-11	-2.53	-2.53
Provision for Credit Losses	3.00	0	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -9.9%
Net margin: -6.6%
Return on equity, FY2025: 373.2%

Financial strength

Current ratio: 0.46
Debt to equity: –
Debt to assets: 18.4%
Cash to current liabilities: 5.5%

Valuation

P/E ratio: –
Price to sales: 0.01
Price to book: –
Dividend yield: –